SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $206,000 | -9.6% | 3,435 | -31.0% | 1.67% | +20.6% |
| Q1 2018 | $228,000 | +111.1% | 4,980 | +83.8% | 1.38% | +104.0% |
| Q4 2017 | $108,000 | 0.0% | 2,710 | 0.0% | 0.68% | +244.7% |
| Q3 2017 | $108,000 | -51.1% | 2,710 | -47.1% | 0.20% | -53.0% |
| Q2 2017 | $221,000 | +38.1% | 5,125 | 0.0% | 0.42% | +29.3% |
| Q1 2017 | $160,000 | – | 5,125 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |